Alpha/Beta T-Cell Depleted Grafts as an Immunological Booster to Treat Graft Failure after Hematopoietic Stem Cell Transplantation with HLA-Matched Related and Unrelated Donors

Figure 5

subsets in PBMC > 3 months after boost. Blood samples were taken 3–7 months (m) after boost from four patients. (a) Subgroups (, , Vδ1, Vδ2, Vγ9, and V24)+ cells of CD3+ T-cells from PBMCs were analyzed. (b) Representative plots of the subsets , , Vδ1, Vδ2, Vγ9, and V24+ cells of CD3+ T-cells from patient 1610, 7 months post boost.

(a)

(b)